ZYDUSLIFE.NS Balance Sheet
Zydus Lifesciences Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 7 years on file
(FY2019-20 to FY2025-26)
· fetched 2026-08-24 01:31
| Line item | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|
| Property, Plant and Equipment | N/A | N/A | N/A | ₹56.97 Bn | ₹58.03 Bn | ₹60.42 Bn | ₹92.31 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | N/A | N/A | N/A | ₹11.30 Bn | ₹11.12 Bn | ₹13.18 Bn | ₹11.66 Bn | CapitalWorkInProgress |
| Goodwill | N/A | N/A | N/A | ₹48.04 Bn | ₹52.66 Bn | ₹52.42 Bn | ₹75.43 Bn | Goodwill |
| Other Intangible Assets | N/A | N/A | N/A | ₹10.20 Bn | ₹12.99 Bn | ₹18.50 Bn | ₹73.32 Bn | OtherIntangibleAssets |
| Non-current Investments | N/A | N/A | N/A | ₹5.11 Bn | ₹5.52 Bn | ₹4.14 Bn | ₹5.97 Bn | NoncurrentInvestments |
| Other Non-current Assets | N/A | N/A | N/A | ₹3.29 Bn | ₹1.97 Bn | ₹3.89 Bn | ₹7.89 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | N/A | N/A | N/A | ₹157.40 Bn | ₹177.79 Bn | ₹201.56 Bn | ₹325.00 Bn | NoncurrentAssets |
| Inventories | N/A | N/A | N/A | ₹34.13 Bn | ₹34.42 Bn | ₹39.44 Bn | ₹56.28 Bn | Inventories |
| Trade Receivables | N/A | N/A | N/A | ₹44.17 Bn | ₹52.20 Bn | ₹40.25 Bn | ₹54.16 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | N/A | N/A | N/A | ₹4.88 Bn | ₹4.13 Bn | ₹8.27 Bn | ₹8.55 Bn | CashAndCashEquivalents |
| Current Investments | N/A | N/A | N/A | ₹6.19 Bn | ₹2.52 Bn | ₹48.51 Bn | ₹57.76 Bn | CurrentInvestments |
| Other Current Assets | N/A | N/A | N/A | ₹7.57 Bn | ₹7.41 Bn | ₹6.79 Bn | ₹14.49 Bn | OtherCurrentAssets |
| Total Current Assets | N/A | N/A | N/A | ₹100.08 Bn | ₹114.20 Bn | ₹170.46 Bn | ₹199.06 Bn | CurrentAssets |
| Total Assets | N/A | N/A | N/A | ₹257.56 Bn | ₹292.81 Bn | ₹372.02 Bn | ₹524.07 Bn | Assets |
| Equity Share Capital | N/A | N/A | N/A | ₹1.01 Bn | ₹1.01 Bn | ₹1.01 Bn | ₹1.01 Bn | EquityShareCapital |
| Other Equity | N/A | N/A | N/A | ₹174.15 Bn | ₹197.29 Bn | ₹238.53 Bn | ₹270.11 Bn | OtherEquity |
| Equity Attributable to Owners | N/A | N/A | N/A | ₹175.16 Bn | ₹198.29 Bn | ₹239.53 Bn | ₹271.11 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | ₹21.73 Bn | ₹22.72 Bn | ₹24.05 Bn | ₹24.71 Bn | NonControllingInterest |
| Total Equity | N/A | N/A | N/A | ₹196.88 Bn | ₹221.02 Bn | ₹263.58 Bn | ₹295.82 Bn | Equity |
| Long-term Borrowings | N/A | N/A | N/A | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹31.88 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | N/A | N/A | N/A | ₹5.37 Bn | ₹18.37 Bn | ₹18.02 Bn | ₹71.12 Bn | NoncurrentLiabilities |
| Short-term Borrowings | N/A | N/A | N/A | ₹11.63 Bn | ₹7.69 Bn | ₹31.70 Bn | ₹85.81 Bn | BorrowingsCurrent |
| Trade Payables | N/A | N/A | N/A | ₹21.25 Bn | ₹21.27 Bn | ₹23.06 Bn | ₹28.45 Bn | TradePayablesCurrent |
| Other Current Liabilities | N/A | N/A | N/A | ₹2.82 Bn | ₹2.78 Bn | ₹2.66 Bn | ₹4.78 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | N/A | N/A | N/A | ₹55.27 Bn | ₹53.40 Bn | ₹90.42 Bn | ₹157.12 Bn | CurrentLiabilities |
| Total Equity and Liabilities | N/A | N/A | N/A | ₹257.56 Bn | ₹292.81 Bn | ₹372.02 Bn | ₹524.07 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from ZYDUSLIFE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).